Asklepios Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-01-2025
- Paid Up Capital ₹ 3.47 M
as on 04-01-2025
- Company Age 35 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 04-01-2025
- Satisfied Charges ₹ 1.15 M
as on 04-01-2025
- Revenue -15.99%
(FY 2020)
- Profit -13.55%
(FY 2020)
- Ebitda 8.41%
(FY 2020)
- Net Worth 6.41%
(FY 2020)
- Total Assets -7.06%
(FY 2020)
About Asklepios Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.47 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹1.15 M, as per Ministry of Corporate Affairs (MCA) records.
Shashikant Kumar, Kumari Nibha, and Anita Prasad serve as directors at the Company.
- CIN/LLPIN
U24230BR1989PTC003434
- Company No.
003434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Asklepios Remedies Pvt Ltd. offer?
Asklepios Remedies Pvt Ltd. offers a wide range of products and services, including Antibiotic Tablets & Capsules, Cefixime Tablet.
Who are the key members and board of directors at Asklepios Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashikant Kumar  | Director | 14-Mar-1990 | Current |
| Kumari Nibha | Director | 29-Sep-2006 | Current |
| Anita Prasad | Director | 29-Sep-2006 | Current |
Financial Performance of Asklepios Remedies.
Asklepios Remedies Pvt Ltd., for the financial year ended 2020, experienced significant reduction in revenue, with a 15.99% decrease. The company also saw a substantial fall in profitability, with a 13.55% decrease in profit. The company's net worth moved up by a moderate rise of 6.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asklepios Remedies?
In 2020, Asklepios Remedies had a promoter holding of 24.85% and a public holding of 75.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Mar 2005 | ₹5.00 M | Open |
Central Bank Of India Creation Date: 09 Feb 2011 | ₹0.50 M | Satisfied |
Central Bank Of India Creation Date: 30 Aug 2003 | ₹0.65 M | Satisfied |
How Many Employees Work at Asklepios Remedies?
Asklepios Remedies has a workforce of 23 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asklepios Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asklepios Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
